Literature DB >> 20938208

Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice.

M H Xu1, Y S Gong, M S Su, Z Y Dai, S S Dai, S Z Bao, N Li, R Y Zheng, J C He, J F Chen, X T Wang.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by sustained elevation of pulmonary vascular resistance resulting from endothelial and smooth muscle cell dysfunction and collagen deposition in pulmonary vascular walls. In this study, we investigated the role of the adenosine A(2A) receptor (A(2A)R) in the development of PAH by determining the effect of genetic inactivation of A(2A)Rs on pulmonary vascular remodeling in mice. METHODS AND
RESULTS: We characterized hemodynamic, histological and ultrastructural changes in pulmonary vascular remodeling in A(2A)R knockout (KO) mice compared with their wild-type (WT) littermates after exposure to normoxia and hypoxic conditions. After exposure to normoxia, compared to WT mice, A(2A)R KO mice displayed: (1) increased right ventricular systolic pressures and an elevated ratio of the right ventricle over left ventricle plus septum (Fulton index), (2) increased wall area and thickness as well as enhanced smooth muscle actin immunoreactivity in pulmonary resistance vessels, (3) increased proliferating cell nuclear antigen-positive cells in pulmonary resistance vessels and (4) increased smooth muscle cells hypertrophy and collagen deposition in the adventitia of pulmonary arteriole walls as revealed by electron microscope. By contrast, histological analysis revealed no features of hypertensive nephropathy in A(2A)R KO mice and there was no significant difference in systemic blood pressure, and left ventricular masses among the 3 genotypes. Furthermore, following chronic exposure to hypoxia, A(2A)R KO mice exhibited exacerbated elevation in right ventricular systolic pressure, hypertrophy of pulmonary resistance vessels and increased cell proliferation in pulmonary resistance vessels, compared to WT littermates. Thus, genetic inactivation of A(2A)Rs selectively produced PAH and associated increased smooth muscle proliferation and collagen deposition.
CONCLUSIONS: Extracellular adenosine acting at A(2A)Rs represents an important regulatory mechanism to control the development of PAH and pulmonary vascular remodeling.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938208      PMCID: PMC2975736          DOI: 10.1159/000316935

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  39 in total

Review 1.  Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs.

Authors:  Bertil B Fredholm; Jiang-Fan Chen; Susan A Masino; Jean-Marie Vaugeois
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 2.  Growth regulation of the vascular system: an emerging role for adenosine.

Authors:  Thomas H Adair
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-08       Impact factor: 3.619

3.  Effect of adenosine on pulmonary circulation of rabbits.

Authors:  H El-Kashef; M M Elmazar; O A Al-Shabanah; A M Al-Bekairi
Journal:  Gen Pharmacol       Date:  1999-03

4.  Habitual caffeine intake and the risk of hypertension in women.

Authors:  Wolfgang C Winkelmayer; Meir J Stampfer; Walter C Willett; Gary C Curhan
Journal:  JAMA       Date:  2005-11-09       Impact factor: 56.272

5.  Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease.

Authors:  Atsushi Sato; Ken Terata; Hiroto Miura; Kazuyoshi Toyama; Fausto R Loberiza; Ossama A Hatoum; Takashi Saito; Ichiro Sakuma; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04       Impact factor: 4.733

6.  Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice.

Authors:  Lunyin Yu; Deborah A Quinn; Hari G Garg; Charles A Hales
Journal:  Circ Res       Date:  2005-09-29       Impact factor: 17.367

7.  Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse.

Authors:  Manasi Nandi; Alyson Miller; Raymond Stidwill; Thomas S Jacques; Amanda A J Lam; Sheila Haworth; Simon Heales; Patrick Vallance
Journal:  Circulation       Date:  2005-04-11       Impact factor: 29.690

8.  Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

Authors:  Charles W Schindler; Marzena Karcz-Kubicha; Eric B Thorndike; Christa E Müller; Srihari R Tella; Sergi Ferré; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

9.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.

Authors:  C Ledent; J M Vaugeois; S N Schiffmann; T Pedrazzini; M El Yacoubi; J J Vanderhaeghen; J Costentin; J K Heath; G Vassart; M Parmentier
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

10.  Involvement of adenosine in the antiinflammatory action of ketamine.

Authors:  Julia Mazar; Boris Rogachev; Gad Shaked; Nadav Y Ziv; David Czeiger; Cidio Chaimovitz; Moshe Zlotnik; Igor Mukmenev; Gerardo Byk; Amos Douvdevani
Journal:  Anesthesiology       Date:  2005-06       Impact factor: 7.892

View more
  23 in total

Review 1.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 2.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

3.  Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Authors:  Adeline Blandinières; Thomas Gille; Jérémy Sadoine; Ivan Bièche; Lofti Slimani; Blandine Dizier; Pascale Gaussem; Catherine Chaussain; Carole Planes; Peter Dorfmüller; Dominique Israël-Biet; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

4.  Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.

Authors:  Yan Wang; Wei Tian; Chunhong Xiu; Ming Yan; Shuya Wang; Yifang Mei
Journal:  Clin Rheumatol       Date:  2018-01-23       Impact factor: 2.980

Review 5.  GPCRs in pulmonary arterial hypertension: tipping the balance.

Authors:  Jean Iyinikkel; Fiona Murray
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

6.  Extracellular adenosine enhances pulmonary artery vasa vasorum endothelial cell barrier function via Gi/ELMO1/Rac1/PKA-dependent signaling mechanisms.

Authors:  Alexander D Verin; Robert Batori; Anita Kovacs-Kasa; Mary Cherian-Shaw; Sanjiv Kumar; Istvan Czikora; Vijaya Karoor; Derek Strassheim; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

7.  Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PI3-kinase and ERK1/2 pathways.

Authors:  Aftab Ahmad; Jerome B Schaack; Carl W White; Shama Ahmad
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

8.  Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats.

Authors:  Allan K N Alencar; Sharlene L Pereira; Tadeu L Montagnoli; Rodolfo C Maia; Arthur E Kümmerle; Sharon S Landgraf; Celso Caruso-Neves; Emanuelle B Ferraz; Roberta Tesch; José H M Nascimento; Carlos M R de Sant'Anna; Carlos A M Fraga; Eliezer J Barreiro; Roberto T Sudo; Gisele Zapata-Sudo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

9.  Purinergic dysregulation in pulmonary hypertension.

Authors:  Scott H Visovatti; Matthew C Hyman; Sascha N Goonewardena; Anuli C Anyanwu; Yogendra Kanthi; Patrick Robichaud; Jintao Wang; Danica Petrovic-Djergovic; Rahul Rattan; Charles F Burant; David J Pinsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-20       Impact factor: 4.733

Review 10.  Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.

Authors:  Jinjutha Silpanisong; William J Pearce
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.